MedPath

The Effect of Initiating Intravenous Oxytocin Infusion before Uterine Incision on Blood Loss During Elective Caesarean Section: A Randomized Clinical Trial

Not Applicable
Completed
Conditions
Post partum haemorrhage prevention
Registration Number
PACTR202111830813291
Lead Sponsor
wigboji Ndukwe Wilson
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
180
Inclusion Criteria

•Singleton pregnancy
•Term pregnancy (37 - 42 weeks gestational age)
•Booked for elective caesarean section,
•Willingness to participate in the study, were included.

Exclusion Criteria

•Women with multiple gestation
•Women with polyhydramnios or macrosomia
•Parturients with antepartum haemorrhage
•Parturients with heart or renal disease
•Women with 2 or more previous CS
•Women with bleeding disorders
•Women with previous history of postpartum haemorrhage
•Women who did not consent to the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
•The mean blood loss during elective caesarean section in the two arms
Secondary Outcome Measures
NameTimeMethod
. The need for additional uterotonics to control bleeding<br>•The need for blood transfusion or additional surgical intervention<br>•Maternal side effects(nausea and vomiting, chest pain, palpitation, maternal death) <br>•Neonatal outcomes of the study groups<br>
© Copyright 2025. All Rights Reserved by MedPath